Navigation Links
Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
Date:4/28/2008

SHELTON, Conn., April 28 /PRNewswire/ -- Cara Therapeutics, Inc. today announced that it has initiated a Phase 1 clinical trial of its long-acting peripheral kappa opioid receptor agonist, CR845. The Phase 1a single-center clinical trial will evaluate the safety, tolerability, pharmacokinetic profile, and pharmacological activity of CR845 in a double-blind, randomized, placebo-controlled, single escalating intravenous dose study in 58 healthy male and female volunteers.

The company is also developing oral and subcutaneous formulations of CR845.

About CR845

In preclinical studies, CR845 was highly selective for the peripheral kappa opioid receptor. Animal studies indicate that CR845 is effective in treating pain of inflammatory, neuropathic and visceral origin and exhibits analgesic efficacy for up to 18 hours after a single dose. Analgesic activity was seen after intravenous, subcutaneous, or oral administration. Unlike currently marketed opioids, CR845 did not inhibit intestinal transit (ileus) or elicit signs of addiction in animal models. Preclinical studies also indicate that CR845 possesses anti-itch activity.

About Cara Therapeutics

Cara Therapeutics is a privately held biotechnology company focused on developing novel, superior therapeutics to treat pain and inflammation associated with diverse medical conditions. Cara's current pipeline includes near-term clinical drug candidates identified as mechanistically distinct, peripherally-acting analgesics.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements relating to the therapeutic applications of CR845 and about Cara's strategy, technologies, pre-clinical and clinical programs, and ability to identify and develop drugs, as well as other statements that are not historical facts. Actual events or results may dif
'/>"/>

SOURCE Cara Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
2. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
3. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
6. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
9. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
10. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
11. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. The delivery of drugs ... in the treatment of neurological disorders. Drugs may ... systematically (e.g., by intravenous injection) for targeted action ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced ... Strategic Business Report" report to their offering. ... Canada , Japan , ... Latin America , and Rest of World. ... Closures in US$ Million by the following Product Segments: Stapler ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Surgical Incision Closures - Global Strategic Business Report 2015 2Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
(Date:6/2/2015)... June 02, 2015 Aidan Booth ... released to public yesterday, and has since received ... senior product reviewer Tiffany Hendricks has weighed in ... of the course on her website HonestyFirstReviews.com. , ... for Internet marketers looking to hone their business ...
(Date:6/2/2015)... June 02, 2015 On March 19th, ... Together” in the Hall of Legends at Detroit’s Ford ... motivational speaker Herman Moore, the goal of the conference ... in today’s society, highlight the benefits of effective professional ... attendees about the options that are available to them ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The Down ... Lauren Potter from the hit show Glee as the ... Awareness Walk in Pleasant Prairie, WI. The event aims ... families in Racine, Kenosha, and Walworth counties. ... Lauren join us for this important event," says Dawn ...
(Date:6/2/2015)... Newark, New Jersey (PRWEB) June 02, 2015 ... Jersey (Horizon BCBSNJ) announced today that its Walking and ... LPGA Classic Presented by Acer, has raised another $3,000 ... LPGA’s Natalie Gulbis undertook the challenge, recording 32,000 steps ... held at Stockton Seaview Hotel & Golf Club in ...
(Date:6/2/2015)... 2015 “ Radaris ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... need on a person. , According to Psychology Today, humans ... on to explain that curiosity is a part of human ...
Breaking Medicine News(10 mins):Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2
... ... Children,s Hospital of Arizona has selected Orion Health™ Rhapsody® Integration Engine ... between clinical systems and the hospital,s electronic medical record (EMR) solution. ... the first interface it created, which linked data from medical devices ...
... LOUIS, Sept. 21 In simultaneous releases published around across the ... against indoor radon, the leading cause of lung cancer among U.S. ... WHO recommendation is to lower radon gas levels by one-third below ... number of U.S. homes needing radon control systems from 8 million ...
... Awardees will work with industry and the FDA to address ... Sept. 21 The U.S. Food and Drug Administration today announced ... of medical devices for children. , , ... A panel of six experts with experience in medicine, business, and ...
... , TORONTO, Sept. 21 Dalton Pharma Services ... services by adding Formulation Development to ... This newly created department is comprised of highly experienced ... equipped with advanced technology and infrastructure to provide clients with ...
... For the past 18 months, Atlantic has been partnering with ... production of a hands-on, interactive exhibit to be installed inside ... an interactive environment that would reduce the anxiety of children ... Morris, Director of Business Development. "At the onset, I didn,t ...
... , , , -- SDA Survey ... -- 2009 Grade Improves from 2008,s C- , , -- ... , WASHINGTON, Sept. 21 Americans appear to be embracing hand hygiene ... as often as we should - especially with the threat of the H1N1 flu virus ...
Cached Medicine News:Health News:Phoenix Children's Hospital Significantly Reduces Costs with Orion Health™ Technology 2Health News:Phoenix Children's Hospital Significantly Reduces Costs with Orion Health™ Technology 3Health News:Phoenix Children's Hospital Significantly Reduces Costs with Orion Health™ Technology 4Health News:World Health Organization Launches New Attack on Lung Cancer 2Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 2Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 3Health News:Dalton Pharma Services Adds Formulation Development Services 2Health News:Atlantic Partners with Children's Hospital of Philadelphia to Create an Interactive & Educational Waiting Room 2Health News:Clean Hands Report Card(R): Americans Get a 'B-' on Hand Hygiene 2Health News:Clean Hands Report Card(R): Americans Get a 'B-' on Hand Hygiene 3
White Standard Girdle...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, Mid-thigh, Front Closure...
Male Body Shaper, Front Closure...
Medicine Products: